Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Mcpherson’S Limited ( (AU:MCP) ) is now available.
McPherson’s Limited has reported expected revenue of $139 million for FY25, with four out of five core brands achieving revenue growth despite challenging conditions. The company has transitioned to a new operating model involving third-party warehousing and pharmacy wholesaler partnerships, which is expected to unlock EBIT benefits of $4 to $5 million annually. This strategic shift is aimed at supporting future growth and enhancing brand investment, positioning McPherson’s for improved operational performance in FY26.
More about Mcpherson’S Limited
McPherson’s Limited is an Australian company that supplies essential health, beauty, and wellness products. It operates five core household brands: Manicare, Lady Jayne, Dr LeWinns, Swisspers, and Fusion Health. The company focuses on growing these brands through pharmacy, grocery, and e-commerce channels, and also offers products in haircare, vitamins and supplements, fragrance, and nutrition. McPherson’s is headquartered in Sydney and is listed on the Australian Securities Exchange.
Average Trading Volume: 288,099
Technical Sentiment Signal: Sell
Current Market Cap: A$38.87M
For a thorough assessment of MCP stock, go to TipRanks’ Stock Analysis page.